|
透雲生物科技集團有限公司, 01332.HK - 財務比率 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
變現能力分析 |
流動比率(倍) |
1.1 |
1.37 |
5.47 |
5.47 |
3.44 |
2.45 |
3.26 |
2.91 |
1.23 |
0.9 |
0.73 |
速動比率(倍) |
1.01 |
1.26 |
5.22 |
5.19 |
3.33 |
1.9 |
2.54 |
2.31 |
0.91 |
0.67 |
0.53 |
償債能力分析 |
長期債項/股東權益(%) |
1.87 |
0.0 |
31.27 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
總債項/股東權益(%) |
48.21 |
30.2 |
31.43 |
1.01 |
25.81 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
總債項/資本運用(%) |
47.03 |
30.18 |
23.93 |
1.01 |
25.8 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
投資回報分析 |
股東權益回報率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
32.76 |
3.79 |
5.14 |
8.21 |
23.06 |
21.76 |
16.7 |
資本運用回報率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
32.76 |
3.75 |
5.1 |
8.11 |
22.58 |
21.2 |
16.18 |
總資產回報率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
25.15 |
3.0 |
4.18 |
6.54 |
13.09 |
8.77 |
5.8 |
盈利能力分析 |
經營利潤率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
89.61 |
3.6 |
4.51 |
6.6 |
11.2 |
9.25 |
7.76 |
稅前利潤率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
89.61 |
3.31 |
4.52 |
6.72 |
11.09 |
9.08 |
7.41 |
邊際利潤率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
89.26 |
2.61 |
3.08 |
5.22 |
9.04 |
7.0 |
5.58 |
營運能力分析 |
存貨周轉率(倍) |
11.16 |
9.82 |
17.65 |
15.5 |
10.22 |
10.52 |
10.49 |
10.77 |
10.73 |
9.08 |
8.45 |
投資收益分析 |
派息比率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
相關統計 |
財政年度周最高價 |
0.776 |
0.35 |
0.55 |
0.445 |
0.696 |
0.333 |
0.95 |
1.71 |
0.0 |
0.0 |
0.0 |
財政年度周最低價 |
0.153 |
0.054 |
0.241 |
0.225 |
0.154 |
0.028 |
0.54 |
0.59 |
0.0 |
0.0 |
0.0 |
財政年度最高市盈率(倍) |
0.0 |
0.0 |
0.0 |
0.0 |
9.97 |
114.83 |
202.13 |
11.45 |
0.0 |
0.0 |
0.0 |
財政年度最低市盈率(倍) |
0.0 |
0.0 |
0.0 |
0.0 |
2.21 |
9.66 |
114.89 |
3.95 |
0.0 |
0.0 |
0.0 |
財政年度最高週息率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
財政年度最低週息率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
|